Johnson and Johnson introduces new vaccine : Ad26.COV.S

image by :

Johnson and Johnson today announced data that demonstrated it’s single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta Variant and other highly prevalent SARS-COV-2 viral variants.

It was developed by Janseen vaccines in Leiden, Netherlands.

Paul Stoffels, M.D., Vice chairman of the Executive committee and chief Scientific officer at Johnson and Johnson said, We believe that our vaccine offers durable protection against COVID-19 and elicits neutralizing activity against the Delta variant.

Johnson and Johnson single-dose COVID-19 vaccine is now available in many regions and countries on a not-for-profit basis during the emergency pandemic period.

Leave a Reply

Your email address will not be published.

Translate »
%d bloggers like this: